Cover Image
市場調查報告書

行動醫療與家庭監測

mHealth and Home Monitoring - 7th Edition

出版商 BERG Insight 商品編碼 227122
出版日期 內容資訊 英文 250 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
行動醫療與家庭監測 mHealth and Home Monitoring - 7th Edition
出版日期: 2015年12月07日 內容資訊: 英文 250 Pages
簡介

行動醫療為提供醫療服務帶來革命,導向更佳治療成果和成本的削減,醫療制度的永續性的改善。引行動醫療解決方案的市場仍處於初期階段,不過今後好幾年將來到持續大幅度成長階段。2015年終,家庭利用醫療用連網型監測設備的患者估計將有300萬人,不過,該數字預計以45.4%的年複合成長率發展,2020年達到1,920萬人。

本報告提供全球行動醫療及家庭監測市場趨勢與預測的相關調查、全球主要地區的醫療制度、償付制度、主要手機業者的行動醫療策略、家庭用連網型監測設備的種類及技術、產品及解決方案供應商詳細內容、市場成長預測、市場成長的各種影響因素分析等綜合性彙整。

摘要整理

第1章 文明病的課題

  • 簡介
  • 一般的慢性疾病
  • 醫療提供者與償付制度
  • 法律制度

第2章 行動醫療平台

  • 行動醫療市場概要
  • 行動醫療連接性解決方案
  • 行動醫療治療提供平台

第3章 生理學的監測解決方案供應商

  • 醫療設備和遠程監控
  • 心臟節奏管理
  • 遠隔心電圖監控
  • 血壓監測
  • 凝血監測
  • 睡眠治療監測
  • 家用睡眠診斷
  • 血中氧監測
  • 空氣循環監測
  • 血糖值監測
  • 其他

第4章 投藥、整合監測解決方案供應商

  • 遠端保健解決方案供應商
  • 服藥遵守監測

第5章 市場分析、預測

  • 市場預測
  • 收益預測
  • 產業趨勢、分析
  • 市場成長促進及阻礙因素
  • 潛在的市場刺激因素

詞彙表

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of home monitoring devices on the global market with integrated cellular connectivity was 3.0 million at the end of 2015 and is forecasted to grow at a CAGR of 45.4 percent in the next five years to reach 19.2 million in 2020. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 250 page in-depth report now in its seventh edition.

Table of Contents

Table of Contents

List of Figures

Executive summary

1. The challenge from welfare diseases

  • 1.1. Introduction
    • 1.1.1. The ageing world population
    • 1.1.2. Metabolic syndrome and lifestyle related diseases
  • 1.2. Common chronic diseases
    • 1.2.1. Cardiac arrhythmia
    • 1.2.2. Ischemic diseases
    • 1.2.3. Hypertension
    • 1.2.4. Sleep apnea
    • 1.2.5. Chronic respiratory diseases
    • 1.2.6. Diabetes
    • 1.2.7. Hyperlipidemia
  • 1.3. Healthcare providers and reimbursement systems
    • 1.3.1. Healthcare in Asia-Pacific
    • 1.3.2. Healthcare in Europe
    • 1.3.3. Healthcare in North America
  • 1.4. Regulatory environment
    • 1.4.1. Regulatory environment in Europe
    • 1.4.2. Regulatory environment in the US
    • 1.4.3. Regulatory environment in other major markets
    • 1.4.4. International standardisation

2. mHealth platforms

  • 2.1. Overview of the mHealth market
    • 2.1.1. mHealth market segments
    • 2.1.2. Connectivity options for medical devices
    • 2.1.3. The mHealth technology value chain
  • 2.2. mHealth connectivity solutions
    • 2.2.1. Apple HealthKit
    • 2.2.2. PTC
    • 2.2.3. eDevice
    • 2.2.4. Ericsson
    • 2.2.5. KORE
    • 2.2.6. Microsoft HealthVault
    • 2.2.7. Orange Healthcare
    • 2.2.8. Qualcomm Life
    • 2.2.9. MedM
    • 2.2.10. Telenor Connexion
    • 2.2.11. Vodafone
  • 2.3. mHealth care delivery platforms
    • 2.3.1. AT&T
    • 2.3.2. BePatient
    • 2.3.3. Domicalis
    • 2.3.4. Exco InTouch
    • 2.3.5. Get Real Health
    • 2.3.6. HealthyCircles
    • 2.3.7. Medixine
    • 2.3.8. OpenTeleHealth
    • 2.3.9. S3 Group
    • 2.3.10. Tactio Health
    • 2.3.11. Verklizan

3. Physiological monitoring solution providers

  • 3.1. Medical devices and remote monitoring
    • 3.1.1. Medical device revenues by market segment
    • 3.1.2. Overview of the remote patient monitoring market
  • 3.2. Cardiac rhythm management
    • 3.2.1. Overview of the CRM device market
    • 3.2.2. Use cases for CRM monitoring
    • 3.2.3. Remote monitoring solution providers
    • 3.2.4. Biotronik
    • 3.2.5. Boston Scientific
    • 3.2.6. Medtronic
    • 3.2.7. LivaNova
    • 3.2.8. St. Jude Medical
  • 3.3. Remote ECG monitoring
    • 3.3.1. Overview of the remote ECG monitoring device market
    • 3.3.2. Use cases for remote ECG monitoring
    • 3.3.3. Remote monitoring solution providers
    • 3.3.4. Aerotel Medical Systems
    • 3.3.5. AliveCor
    • 3.3.6. BioTelemetry
    • 3.3.7. CardioComm Solutions
    • 3.3.8. LifeWatch
    • 3.3.9. ScottCare
    • 3.3.10. TZ Medical
    • 3.3.11. Zenicor
  • 3.4. Blood pressure monitoring
    • 3.4.1. Overview of the blood pressure monitoring device market
    • 3.4.2. Use cases for blood pressure monitoring
    • 3.4.3. Remote monitoring solution providers
    • 3.4.4. Omron Healthcare
    • 3.4.5. A&D Medical
    • 3.4.6. Microlife
    • 3.4.7. Rossmax
    • 3.4.8. Sotera Wireless
  • 3.5. Coagulation monitoring
    • 3.5.1. Overview of the coagulation monitoring device market
    • 3.5.2. Use cases for blood coagulation monitoring
    • 3.5.3. Remote monitoring solution providers
    • 3.5.4. Accriva Diagnostics
    • 3.5.5. Alere
    • 3.5.6. CoaguSense
    • 3.5.7. Helena Laboratories
    • 3.5.8. iLine Microsystems
    • 3.5.9. Siemens Healthcare Diagnostics
    • 3.5.10. Roche Diagnostics
  • 3.6. Sleep therapy monitoring
    • 3.6.1. Overview of the sleep therapy device market
    • 3.6.2. Use cases for sleep therapy monitoring
    • 3.6.3. Remote monitoring solution providers
    • 3.6.4. Fisher & Paykel Healthcare
    • 3.6.5. Philips Respironics
    • 3.6.6. ResMed
    • 3.6.7. SRETT
    • 3.6.8. SomnoMed
    • 3.6.9. Weinmann
  • 3.7. Home sleep diagnostics
    • 3.7.1. Overview of the home sleep diagnostics market
    • 3.7.2. Use cases for home sleep diagnostics
    • 3.7.3. Remote monitoring solution providers
    • 3.7.4. Cadwell Laboratories
    • 3.7.5. CareFusion
    • 3.7.6. Compumedics
    • 3.7.7. Infoscan
    • 3.7.8. Natus Medical
    • 3.7.9. NovaSom
    • 3.7.10. SleepMed
    • 3.8. Blood oxygen monitoring
    • 3.8.1. Overview of the blood oxygen monitoring device market
    • 3.8.2. Use cases for blood oxygen monitoring
    • 3.8.3. Remote monitoring solution providers
    • 3.8.4. ChoiceMMed
    • 3.8.5. Masimo
    • 3.8.6. Nonin Medical
  • 3.9. Air flow monitoring
    • 3.9.1. Overview of the air flow monitoring device market
    • 3.9.2. Use cases for air flow monitoring
    • 3.9.3. Remote monitoring solution providers
    • 3.9.4. Aerocrine
    • 3.9.5. AstraZeneca
    • 3.9.6. Clement Clarke International
    • 3.9.7. iSonea
    • 3.9.8. Medical International Research
    • 3.9.9. Ndd Medizintechnik
    • 3.9.10. nSpire Health
    • 3.9.11. Propeller Health
    • 3.9.12. Sibelmed
    • 3.9.13. Vitalograph
  • 3.10. Glucose level monitoring
    • 3.10.1. Overview of the glucose monitoring device market
    • 3.10.2. Use cases for glucose monitoring
    • 3.10.3. Remote monitoring solution providers
    • 3.10.4. Abbott
    • 3.10.5. Bayer Healthcare
    • 3.10.6. BodyTel
    • 3.10.7. Johnson & Johnson
    • 3.10.8. Roche Diabetes Care
    • 3.10.9. Dexcom
    • 3.10.10. Voluntis
    • 3.10.11. Telcare
    • 3.10.12. WellDoc
  • 3.11. Other
    • 3.11.1. Implantable medical devices
    • 3.11.2. Home hemodialysis
    • 3.11.3. Telerehabilitation

4. Medication and integrated monitoring solution providers

  • 4.1. Telehealth and multiparameter monitoring solutions
    • 4.1.1. Overview of the telehealth solutions market
    • 4.1.2. Use cases for telehealth solutions
    • 4.1.3. Telehealth solution providers
    • 4.1.4. Optum
    • 4.1.5. AuthentiDate
    • 4.1.6. Bosch Healthcare
    • 4.1.7. Cardiocom
    • 4.1.8. Care Innovations
    • 4.1.9. H2AD
    • 4.1.10. Honeywell Life Care Solutions
    • 4.1.11. Ideal Life
    • 4.1.12. Medvivo
    • 4.1.13. Philips Hospital to Home
    • 4.1.14. SHL Telemedicine
    • 4.1.15. Telefónica
    • 4.1.16. Tunstall Healthcare Group
    • 4.1.17. Vitaphone
  • 4.2. Medication compliance monitoring
    • 4.2.1. Overview of the medication compliance monitoring market
    • 4.2.2. Use cases for medication compliance monitoring
    • 4.2.3. Compliance monitoring solution providers
    • 4.2.4. DayaMed
    • 4.2.5. Evondos
    • 4.2.6. InRange Systems
    • 4.2.7. Medicpen
    • 4.2.8. Merck
    • 4.2.9. Compliance Meds Technologies
    • 4.2.10. MedSignals
    • 4.2.11. Philips Medido
    • 4.2.12. Proteus Digital Health

5. Market analysis and forecasts

  • 5.1. Market forecasts
    • 5.1.1. Cardiac rhythm management
    • 5.1.2. Sleep therapy
    • 5.1.3. Telehealth and multiparameter monitoring
    • 5.1.4. ECG monitoring
    • 5.1.5. Glucose level monitoring
    • 5.1.6. Medication compliance monitoring
    • 5.1.7. Other medical devices
  • 5.2. Revenue forecasts
    • 5.2.1. Medical monitoring devices
    • 5.2.2. mHealth connectivity solutions
    • 5.2.3. Care delivery platforms
    • 5.2.4. mHealth care programs
  • 5.3. Industry trends and analysis
    • 5.3.1. New players enter the market
    • 5.3.2. Pharmaceutical companies prepare large-scale rollouts
    • 5.3.3. Consumerisation of medical-grade mHealth devices and apps
    • 5.3.4. BYOD is becoming a viable option
    • 5.3.5. Digitalisation of PSTN networks
    • 5.3.6. Modularization of the value chain
  • 5.4. Market drivers and barriers
    • 5.4.1. An ageing population
    • 5.4.2. Increasing welfare disease prevalence
    • 5.4.3. Focus on disease prevention
    • 5.4.4. Substitutes to medical monitoring
    • 5.4.5. Resistance to change
    • 5.4.6. Alignment of financial incentives
  • 5.5. Potential market catalysts
    • 5.5.1. Increased monitoring during clinical trials
    • 5.5.2. Incentives from insurance companies and payers
    • 5.5.3. National health systems support remote monitoring
    • 5.5.4. New clinical evidence on cost effectiveness
    • 5.5.5. Non-prescribed monitoring and healthcare consumerism
  • Glossary

List of Figures

  • Figure 1.1: Population by age group (EU, North America and Japan 2015-2030)
  • Figure 1.2: Direct and indirect costs of chronic welfare diseases in the US and EU
  • Figure 1.3: Number of people suffering from chronic welfare diseases (EU/US 2008)
  • Figure 1.4: Percentage of population diagnosed with chronic welfare diseases
  • Figure 1.5: Total and per capita healthcare spending by country (2013)
  • Figure 1.6: Healthcare expenditure per capita by country (World 2013)
  • Figure 1.7: Share of population covered by private health insurance by country
  • Figure 1.8: Healthcare spending by type of service and product (US 2013)
  • Figure 2.1: mHealth market segments
  • Figure 2.2: Connected medical devices and the provision of care
  • Figure 2.3: Overview of the mHealth technology value chain
  • Figure 2.4: Main focus areas of mHealth connectivity solution providers
  • Figure 2.5: HealthGO+ and HealthGO Mini by eDevice
  • Figure 2.6: Examples of HealthVault-certified devices
  • Figure 2.7: MedM mobile applications
  • Figure 2.8: Examples of mHealth software products and platforms
  • Figure 2.9: BP eHealth Platform patient dashboard
  • Figure 2.10: Medixine Suite
  • Figure 3.1: Medical device market revenues by segment (World 2014-2020)
  • Figure 3.2: Connected medical devices by segment (World 2015)
  • Figure 3.3: Implantable cardiac rhythm management vendor market shares (2014)
  • Figure 3.4: Examples of implantable CRM devices
  • Figure 3.5: Examples of remote monitoring devices
  • Figure 3.6: Market shares for remote monitoring of CRM implants (2015)
  • Figure 3.7: CardioMessenger devices
  • Figure 3.8: Latitude NXT Wave wireless communicator
  • Figure 3.9: The Merlin.net interface and Merlin@Home transmitter
  • Figure 3.10: The Infinity DBS System
  • Figure 3.11: MCT sensor and monitor from CardioNet
  • Figure 3.12: Implantable loop recorder from Medtronic
  • Figure 3.13: AliveCor Mobile ECG third generation
  • Figure 3.14: AliveCor's AliveECG app
  • Figure 3.15: HeartCheck devices from CardioComm Solutions
  • Figure 3.16: Blood pressure monitor from Omron Healthcare
  • Figure 3.17: Sleep therapy vendor market shares (2014)
  • Figure 3.18: ResMed S9 CPAP device with FX Series masks
  • Figure 3.19: Connected sleep therapy solutions by vendor (2015)
  • Figure 3.20: DreamMapper mobile application
  • Figure 3.21: ResMed myAir
  • Figure 3.22: SRETT T4P and TeleOx
  • Figure 3.23: Weinmann prisma25S sleep therapy device
  • Figure 3.24: Examples of home sleep diagnostics companies and products
  • Figure 3.25: iSpO2 and MightySat device and application
  • Figure 3.26: Turbu+ inhaler sensor and app
  • Figure 3.27: iSonea's device and asthma management app
  • Figure 3.28: Propeller Health's asthma management app and inhaler sensor
  • Figure 3.29: Blood glucose meter vendor market shares (2014)
  • Figure 3.30: CGM and insulin delivery system vendor market shares (2014)
  • Figure 3.31: Medication usage by diabetes patients (US 2011)
  • Figure 3.32: Glucose meters from LifeScan and Roche
  • Figure 3.33: Dexcom G4 CGM system
  • Figure 3.34: Asante Pearl insulin pump
  • Figure 3.35: Examples of connected blood glucose meters
  • Figure 3.36: Examples of connected CGM and insulin pump systems
  • Figure 3.37: FreeStyle Libre Flash glucose meter
  • Figure 3.38: Roche Accu-Chek Connect app
  • Figure 3.39: Dexcom G5 app and transmitter
  • Figure 3.40: WellDoc BlueStar
  • Figure 4.1: Overview of the telehealth and multiparameter monitoring landscape
  • Figure 4.2: Installed base of telehealth hubs by region (2015)
  • Figure 4.3: Telehealth hub vendor market shares (2015)
  • Figure 4.4: Cardiocom LinkView and Omnivisor
  • Figure 4.5: The Health Harmony solution
  • Figure 4.6: The Twitoo telehealth hub
  • Figure 4.7: The Honeywell Genesis DM telehealth monitor with peripherals
  • Figure 4.8: eCareCompanion and eCareCoordinator
  • Figure 4.9: Compliance monitoring solution form factors
  • Figure 4.10: The DayaMed MedPod
  • Figure 4.11: The Evondos E300 Automatic Medicine Dispenser
  • Figure 4.12: The EMMA medication management system
  • Figure 4.13: The Easypod injector and the Easypod connect transmitter
  • Figure 4.14: The CleverCap dispenser
  • Figure 4.15: The Philips Medido medication dispenser
  • Figure 5.1: Connected home medical monitoring devices (World 2014-2020)
  • Figure 5.2: Connected home medical monitoring devices by region (World 2014-2020)
  • Figure 5.3: Connected cardiac rhythm management devices (World 2014-2020)
  • Figure 5.4: Connected sleep therapy devices (World 2014-2020)
  • Figure 5.5: Telehealth hubs (World 2014-2020)
  • Figure 5.6: Connected ECG monitoring devices (World 2014-2020)
  • Figure 5.7: Connected glucose monitoring devices (World 2014-2020)
  • Figure 5.8: Connected medication monitoring solutions (World 2014-2020)
  • Figure 5.9: Other connected medical devices (World 2014-2020)
  • Figure 5.10: Remote patient monitoring revenues (World 2014-2020)
  • Figure 5.11: Connected medical device revenues (World 2014-2020)
  • Figure 5.12: mHealth connectivity solution revenues (World 2014-2020)
  • Figure 5.13: Care delivery platform revenues (World 2014-2020)
  • Figure 5.14: Monitoring service revenues (World 2014-2020)
  • Figure 5.15: New players enter the connected care market
  • Figure 5.16: Examples of landmark events in 2015 for healthcare consumerisation
Back to Top